Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 ...

Amid an outpouring of pharma investment dollars into China, Novartis is the latest multinational drugmaker lining up to ...

Forbes contributors publish independent expert analyses and insights. Expert in AI for healthcare and longevity biotechnology Sep 27, 2023, 12:53pm EDT This article is more than 2 years old. The ...

Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

D&D Pharmatech has secured $51 million to fund clinical development across its five subsidiaries, including phase 2 trials in fatty liver disease, Parkinson's and Alzheimer's. The series C, originally ...

2026 kicked off with a stream of AI platform deals across pharma, signaling a cultural shift away from single-asset bets and toward investment in AI infrastructure for broad discovery. The ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful closing of a ...

Pharmacists deliver life-changing healthcare. Their compassionate guidance educates patients on how to make the safest and best use of their prescribed medications. The University of Wyoming School of ...

SALZBURG, Austria--(BUSINESS WIRE)--After successfully launching the D-mine ® Pump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson´s patients, EVER ...